Trials / Completed
CompletedNCT03690778
The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.
A Randomized, Open-label, Single Dose, Crossover Study to Compare the Pharmacokinetic Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 (1000/10mg) in Healthy Male Volunteers.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Jeil Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
A randomized, open-label, single dose, crossover study to compare the pharmacokinetic characteristics of the co-administration of metformin SR and rosuvastatin and JLP-1310 in healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | "Metformin" and "Rosuvastatin" seperately | administration of "Metformin" and "Rosuvastatin" seperately |
| DRUG | JLP-1310 | administration of JLP-1310 |
Timeline
- Start date
- 2018-10-04
- Primary completion
- 2019-02-01
- Completion
- 2019-02-01
- First posted
- 2018-10-01
- Last updated
- 2019-03-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03690778. Inclusion in this directory is not an endorsement.